These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19359449)

  • 1. Brain-derived neurotrophic factor Val66Met polymorphism: association with psychopathological symptoms of schizophrenia?
    Chang HA; Lu RB; Shy MJ; Chang CC; Lee MS; Huang SY
    J Neuropsychiatry Clin Neurosci; 2009; 21(1):30-7. PubMed ID: 19359449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BDNF Val66Met polymorphism and anxiety/depression symptoms in schizophrenia in a Chinese Han population.
    Sun MM; Yang LM; Wang Y; Feng X; Cui KY; Liu LF; Chen ZY
    Psychiatr Genet; 2013 Jun; 23(3):124-9. PubMed ID: 23532065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association study of brain-derived neurotrophic factor Val66Met polymorphism and clinical characteristics of first episode schizophrenia].
    Sun MM; Liu LF; Yang LM; Wang Y; Cui KY; Wang LN; Li CL; Qiao DD; Wang RZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):155-8. PubMed ID: 22487823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking and BDNF Val66Met polymorphism in male schizophrenia: a case-control study.
    Zhang XY; Chen DC; Tan YL; Luo X; Zuo L; Lv MH; Shah NN; Zunta-Soares GB; Soares JC
    J Psychiatr Res; 2015 Jan; 60():49-55. PubMed ID: 25455509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
    Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF serum concentrations in first psychotic episode drug-naïve schizophrenic patients: associations with personality and BDNF Val66Met polymorphism.
    Sotiropoulou M; Mantas C; Bozidis P; Marselos M; Mavreas V; Hyphantis T; Antoniou K
    Life Sci; 2013 Mar; 92(4-5):305-10. PubMed ID: 23333821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression.
    Skibinska M; Groszewska A; Kapelski P; Rajewska-Rager A; Pawlak J; Dmitrzak-Weglarz M; Szczepankiewicz A; Twarowska-Hauser J
    Pharmacol Rep; 2018 Feb; 70(1):55-59. PubMed ID: 29331787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.
    Mezquida G; Penadés R; Cabrera B; Savulich G; Lobo A; González-Pinto A; Penzol MJ; Corripio I; Fernandez-Egea E; Gassó P; Cuesta MJ; Bernardo M;
    Eur Psychiatry; 2016 Oct; 38():61-69. PubMed ID: 27668551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BDNF val66met polymorphism is associated with age at onset and intensity of symptoms of paranoid schizophrenia in a Polish population.
    Suchanek R; Owczarek A; Paul-Samojedny M; Kowalczyk M; Kucia K; Kowalski J
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):88-94. PubMed ID: 23487199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients.
    Kang SG; Choi JE; An H; Lim SW; Lee HJ; Han C; Kim YK; Kim SH; Cho SN; Lee MS; Joe SH; Jung IK; Kim L
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1545-8. PubMed ID: 18602732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
    Hashim HM; Fawzy N; Fawzi MM; Karam RA
    J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis.
    Xu MQ; St Clair D; Ott J; Feng GY; He L
    Schizophr Res; 2007 Mar; 91(1-3):6-13. PubMed ID: 17289348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between the Val66Met polymorphism of brain-derived neurotrophic factor gene and schizophrenia in Russians].
    Golimbet VE; Korovaĭtseva GI; Abramova LI; Kasparov SV; Uvarova LG
    Mol Biol (Mosk); 2008; 42(4):599-603. PubMed ID: 18856059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients.
    Zhou DH; Yan QZ; Yan XM; Li CB; Fang H; Zheng YL; Zhang CX; Yao HJ; Chen DC; Xiu MH; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):930-3. PubMed ID: 20420877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between brain-derived neurotrophic factor G196A gene polymorphism and clinical phenotypes in schizophrenia patients.
    Huang TL; Lee CT
    Chang Gung Med J; 2007; 30(5):408-13. PubMed ID: 18062171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation.
    Szeszko PR; Lipsky R; Mentschel C; Robinson D; Gunduz-Bruce H; Sevy S; Ashtari M; Napolitano B; Bilder RM; Kane JM; Goldman D; Malhotra AK
    Mol Psychiatry; 2005 Jul; 10(7):631-6. PubMed ID: 15768049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased serum brain-derived neurotrophic factor (BDNF) is associated with post-stroke depression but not with BDNF gene Val66Met polymorphism.
    Zhou Z; Lu T; Xu G; Yue X; Zhu W; Ma M; Liu W; Zhu S; Liu X
    Clin Chem Lab Med; 2011 Feb; 49(2):185-9. PubMed ID: 21143020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF Val66Met genetic variation and its plasma level in patients with morbid obesity: A case-control study.
    Zamani M; Hosseini SV; Behrouj H; Erfani M; Dastghaib S; Ahmadi M; Shamsdin SA; Mokarram P
    Gene; 2019 Jul; 705():51-54. PubMed ID: 31004714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: Evidence from a case-control study and meta-analysis.
    Naoe Y; Shinkai T; Hori H; Fukunaka Y; Utsunomiya K; Sakata S; Matsumoto C; Shimizu K; Hwang R; Ohmori O; Nakamura J
    Neurosci Lett; 2007 Mar; 415(2):108-12. PubMed ID: 17267117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.